A single-arm phase II study enrolling 37 patients with Rb-positive metastatic BC showed that of the 84% of ER-positive/HER2-negative BC patients, two had partial remission and five had stable disease for more than 6 months. The gene discussed is ERBB2; the disease is breast cancer.